LOXO-305

pirtobrutinib · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for LOXO-305, covering 2024-07-16 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL [Phase 1, Phase 2]